Goodman Noah sold KYMR
June 25, 2026 · Form 4 insider transaction
Goodman Noah sold 2,500 shares of Kymera Therapeutics, Inc. at $109.00 per share, a transaction worth $272.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$109.00
Total value
$272.5K
InsiderGoodman Noah
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 25, 2026
Filing dateJune 25, 2026
Shares owned after52,695
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.